Why the study?
Are increased concentrations of remnant cholesterol associated with increased all-cause mortality in patients with ischemic heart disease?
Are increased concentrations of remnant cholesterol associated with increased all-cause mortality in patients with ischemic heart disease?
Increased remnant cholesterol, rather than measured LDL cholesterol, explains part of the residual risk of all-cause mortality in patients with ischemic heart disease.
Answers are grounded in this paper and cite their sources.
Remnant cholesterol may mark residual mortality risk in ischemic heart disease; hypothesis-generating and should not yet change practice.
Increased concentrations of both calculated and measured remnant cholesterol were associated with increased all-cause mortality in patients with ischemic heart disease, which was not the case for increased concentrations of measured LDL cholesterol. This suggests that increased concentrations of remnant cholesterol explain part of the residual risk of all-cause mortality in patients with ischemic heart disease.
No takes yet. Share an insight, caveat, or question.
Jepsen et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: